SecProbe.io

Probe score transparency
Intelligence Terminal Search Topics Monthly Activity About

Probe Score Transparency

Inhibitor Therapeutics, Inc. (INTI)
Score window: Apr. 15, 2025 to Apr. 14, 2026

Back View Correspondence
Probe Score
3.5 / 10
Letters
2
Latest Activity
Sep. 15, 2025
Version
v1

Score Breakdown

Letter Count
2.0
Sentiment / Tone
1.5
Keywords
0.0
Signals
0.0
Notable 8-K Modifier
0.0
Notable 8-K Count
0

Matched Signals

No stored keyword or signal matches were recorded for this score.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Sep. 15, 2025 UPLOAD Neutral/Informational Low The SEC has completed its review of Inhibitor Therapeutics, Inc.'s Form 10-K for the year ended December 31, 2024. They remind the company that it is ultimately responsible for th… Read Filing EDGAR
Jul. 22, 2025 CORRESP Neutral/Informational Low Inhibitor Therapeutics, Inc. has submitted a response to the SEC's comment letter regarding their Form 10-K for the fiscal year ended December 31, 2024. The SEC requested addition… Read Filing EDGAR
Jul. 17, 2025 UPLOAD Concern from SEC High The SEC has reviewed Inhibitor Therapeutics, Inc.'s Form 10-K for the year ended December 31, 2024, and has requested additional information regarding an Exclusive License Agreeme… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.